Lalitha Nayak MD

Hematologic Oncology

Instructor, Medicine, Case Western Reserve University School of Medicine

1030 W Michigan StFl 2Indianapolis, IN 46202
Phone+1 317-944-0920
Fax+1 216-844-5759

Dr. Nayak is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Nayak's full profile Already have an account?

Summary

Dr. Lalitha Nayak is an oncologist in Cleveland, OH and is affiliated with University Hospitals Cleveland Medical Center. She received her medical degree from Goa Medical College and has been in practice 23 years. She specializes in hematologic oncology and is experienced in thrombotic disorders, bleeding disorders, and general / benign hematology.

Education & Training

Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
Allegheny Health Network Medical Education Consortium (AGH)Residency, Internal Medicine, 2001 - 2003
Goa Medical CollegeClass of 1994

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

IN State Medical License 2024 - 2027
OH State Medical License 2008 - 2026
PA State Medical License 2001 - 2010
KY State Medical License 2007 - 2008
American Board of Internal Medicine Hematology

Clinical Trials

Sickle Cell Disease Biofluid Chip Technology (SCD BioChip)
RECRUITING
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

A multicenter analysis revisiting the PLASMIC score: performance limitations and the impact of age, MCV, and LDH.
Rishabh Singh, Ashley Khouri, Ho Jun Lee, Sanjana Kalvehalli Kashinath, Mukul Singal
Blood Vessels, Thrombosis & Hemostasis. 2026-05-01
Epigenetic metabolite lipid nanoparticles alleviate venous thrombosis via bone marrow reprogramming.
Lin Di, Natalie E Hong, Oleksandra Pavlova, Courteney Asase, Stephanie Lapping
Blood Vessels, Thrombosis & Hemostasis. 2025-11-01
1 citations
Neutrophil KLF2 regulates inflammasome-dependent neonatal mortality from endotoxemia.
Devashis Mukherjee, Sriram Satyavolu, Asha Thomas, Sarah Cioffi, Yuexin Li
Journal of Leukocyte Biology. 2025-05-07

Abstracts/Posters

Assessment of Bleeding Phenotype in Hemophilia _ By a Novel Point-of-Care Global Assay
Lalitha V. Nayak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Outcomes after Treatment with Upfront Cyclophosphamide or Rituximab for Initial Acquired Thrombotic Thrombocytopenic Purpura
Lalitha V. Nayak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Venous Thromboembolism (VTE) in Sickle Cell Disease (SCD) Is Associated with Neutrophilia
Lalitha V. Nayak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Friday Scientific Workshop on the Interplay Between Coagulation and Malignancy
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Laboratory & Translational Hematology
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Hepatocyte-Derived Tissue Plasminogen Activator Regulates Systemic Fibrinolysis
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

The Research Could Lead to Safer Ways to Treat Patients with Blood ClotsOctober 2nd, 2022
Cancer Drug Boosts Levels of Vascular-Protective Gene, KLF2June 12th, 2014